Lyell Immunopharma, Inc

Contributing Author

Recent Articles by Lyell Immunopharma, Inc

Jun-23	Lyell Immunopharma to Participate in the H.C. Wainwright "HCW@Home" Series LYEL GlobeNewswire
Jun-17	Lyell Immunopharma Announces Positive New Clinical Data Demonstrating High Rates of Durable Complete Responses from the Phase 1/2 Trial of LYL314 for the Treatment of Aggressive Large B-cell Lymphoma LYEL GlobeNewswire
Jun-09	Lyell Immunopharma Strengthens Clinical and Commercial Capabilities with Key Board and Executive Appointments LYEL GlobeNewswire
Jun-04	Lyell Immunopharma to Participate in the Goldman Sachs Global Healthcare Conference LYEL GlobeNewswire
May-13	Lyell Immunopharma Reports Business Highlights and Financial Results for the First Quarter 2025 LYEL GlobeNewswire